Humboldt Fund logo

Humboldt Fund

North America, New York, United States, New York

Description

Humboldt Fund is an investment firm that seeks to invests in bio revolution companies.

Investor Profile

Humboldt Fund has made 24 investments, with 0 in the past 12 months and 17% as lead.

Stage Focus

  • Series A (33%)
  • Seed (25%)
  • Series B (21%)
  • Series Unknown (13%)
  • Pre Seed (4%)
  • Series D (4%)

Country Focus

  • United States (88%)
  • The Netherlands (4%)
  • China (4%)
  • Switzerland (4%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Food And Beverage
  • Health Care
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Life Science
  • Biopharma
  • Medical
  • Beauty
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Humboldt Fund frequently co-invest with?

HOF Capital
North America, New York, United States, New York
Co-Investments: 3
Agent Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
SOSV
North America, New Jersey, United States, Princeton
Co-Investments: 3
Mubadala Capital Ventures
North America, California, United States, San Francisco
Co-Investments: 3
8VC
North America, California, United States, San Francisco
Co-Investments: 4
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 2
Horizons Ventures
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 3
YC
Europe, Zug, Switzerland, Zug
Co-Investments: 2
Leaps by Bayer
Europe, Nordrhein-Westfalen, Germany, Leverkusen
Co-Investments: 4

Which angels does Humboldt Fund often collaborate with?

TF
Europe, Ile-de-France, France, Paris
Shared Deals: 1
JL
North America, Nevada, United States, Las Vegas
Shared Deals: 1
George Godula
Asia, Shanghai, China, Shanghai
Shared Deals: 1
JL
North America, Massachusetts, United States, Boston
Shared Deals: 1
RK
North America, California, United States
Shared Deals: 1
VW
North America, Florida, United States, Miami Beach
Shared Deals: 1
KM
North America, Washington, United States, Seattle
Shared Deals: 1
AB
North America, United States
Shared Deals: 1
TH
Europe, England, United Kingdom, London
Shared Deals: 1
NP
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Humboldt Fund?

Spiral Therapeutics

San Francisco, California, United States

Spiral Therapeutics is a clinical-stage pharmaceutical company delivering therapies for hearing loss.

BiotechnologyHealth CareMedicalPharmaceutical
Series UnknownJan 9, 2023
Amount Raised: $8,250,000
Deciduous Therapeutics

San Francisco, California, United States

Deciduous Therapeutics is an aging therapeutics company developing a novel class of immune modulatory therapies.

BiopharmaBiotechnologyHealth Care
SeedDec 31, 2022
Amount Raised: $10,000,000
Endpoint Health

Palo Alto, California, United States

Endpoint Health is a precision immunology company

Health Care
Series AJun 2, 2022
Amount Raised: $52,000,000
Ansa Biotechnologies

Emeryville, California, United States

Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.

BiotechnologyLife ScienceTherapeutics
Series AApr 11, 2022
Amount Raised: $68,000,000
Affini-T Therapeutics

Watertown, Massachusetts, United States

Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.

BiotechnologyHealth CareTherapeutics
Series UnknownMar 22, 2022
Amount Raised: $175,000,000
Finless Foods

Emeryville, California, United States

Finless Foods provides cellular-agriculture technologies to create accessible plant-based and cell-cultured seafood alternatives.

Consumer GoodsFood and BeverageSustainability
Series BMar 2, 2022
Amount Raised: $34,000,000
HAYA Therapeutics

Lausanne, Vaud, Switzerland

HAYA Therapeutics is a biopharmaceutical company that specializes in treating heart failure diseases.

BiopharmaBiotechnologyHealth CareMedical
SeedFeb 9, 2022
Amount Raised: $5,000,000
Cellino

Cambridge, Massachusetts, United States

Cellino is building a scalable, automated biomanufacturing system for potentially curative personalized cell therapies.

BiotechnologyNanotechnologyProduct Design
Series AJan 25, 2022
Amount Raised: $80,000,000
Metagenomi

Emeryville, California, United States

Metagenomi uses metagenomics and machine learning to discover novel genome editing systems for therapeutics development.

Artificial Intelligence (AI)BiotechnologyMachine LearningTherapeutics
Series BJan 25, 2022
Amount Raised: $175,000,000
Ansa Biotechnologies

Emeryville, California, United States

Ansa Biotechnologies develops a novel DNA synthesis technology based on enzymes.

BiotechnologyLife ScienceTherapeutics
Series UnknownOct 15, 2021
Amount Raised: $5,000,000